- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
- You can view the full Johnson & Johnson Ratings Report.
Newly public companies such as Roku, NuCana and Restoration Robotics could bring a jolt to your portfolio. But remember all IPOs aren't created equally.
U.S. companies that have significant sales in Europe are about to reap the benefits of a weak greenback. These big-names will especially be winners.
Johnson & Johnson had a very good acquisition
The firm's bearish outlook on JNJ is predicated on pressure weighed on crucial products at the company, combined with a slowdown in growth at its Medical Devices unit.